221 related articles for article (PubMed ID: 15288255)
1. Emerging classes of protein-protein interaction inhibitors and new tools for their development.
Pagliaro L; Felding J; Audouze K; Nielsen SJ; Terry RB; Krog-Jensen C; Butcher S
Curr Opin Chem Biol; 2004 Aug; 8(4):442-9. PubMed ID: 15288255
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein-protein interactions using designed molecules.
Wilson AJ
Chem Soc Rev; 2009 Dec; 38(12):3289-300. PubMed ID: 20449049
[TBL] [Abstract][Full Text] [Related]
3. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
Buchwald P
IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
[TBL] [Abstract][Full Text] [Related]
5. Disruption of protein-protein interactions: towards new targets for chemotherapy.
Loregian A; Palù G
J Cell Physiol; 2005 Sep; 204(3):750-62. PubMed ID: 15880642
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Between a rock and a hard place?
Whitty A; Kumaravel G
Nat Chem Biol; 2006 Mar; 2(3):112-8. PubMed ID: 16484997
[TBL] [Abstract][Full Text] [Related]
8. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
White AW; Westwell AD; Brahemi G
Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
[TBL] [Abstract][Full Text] [Related]
9. Peptidic modulators of protein-protein interactions: progress and challenges in computational design.
Rubinstein M; Niv MY
Biopolymers; 2009 Jul; 91(7):505-13. PubMed ID: 19226619
[TBL] [Abstract][Full Text] [Related]
10. A large-scale computational approach to drug repositioning.
Li YY; An J; Jones SJ
Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.
Arkin MR; Wells JA
Nat Rev Drug Discov; 2004 Apr; 3(4):301-17. PubMed ID: 15060526
[No Abstract] [Full Text] [Related]
12. A systems biology perspective on protein structural dynamics and signal transduction.
Rousseau F; Schymkowitz J
Curr Opin Struct Biol; 2005 Feb; 15(1):23-30. PubMed ID: 15718129
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting protein-protein interactions using designed molecules.
Zhao L; Chmielewski J
Curr Opin Struct Biol; 2005 Feb; 15(1):31-4. PubMed ID: 15718130
[TBL] [Abstract][Full Text] [Related]
14. Diversity-oriented synthesis: exploring the intersections between chemistry and biology.
Tan DS
Nat Chem Biol; 2005 Jul; 1(2):74-84. PubMed ID: 16408003
[TBL] [Abstract][Full Text] [Related]
15. Rational drug design via intrinsically disordered protein.
Cheng Y; LeGall T; Oldfield CJ; Mueller JP; Van YY; Romero P; Cortese MS; Uversky VN; Dunker AK
Trends Biotechnol; 2006 Oct; 24(10):435-42. PubMed ID: 16876893
[TBL] [Abstract][Full Text] [Related]
16. Modulation of protein-protein interactions with small organic molecules.
Berg T
Angew Chem Int Ed Engl; 2003 Jun; 42(22):2462-81. PubMed ID: 12800163
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
18. Strategies for targeting protein-protein interactions with synthetic agents.
Yin H; Hamilton AD
Angew Chem Int Ed Engl; 2005 Jul; 44(27):4130-63. PubMed ID: 15954154
[TBL] [Abstract][Full Text] [Related]
19. Creating the next generation of protein therapeutics through rational drug design.
Szymkowski DE
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):590-600. PubMed ID: 16159021
[TBL] [Abstract][Full Text] [Related]
20. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
Block P; Weskamp N; Wolf A; Klebe G
Proteins; 2007 Jul; 68(1):170-86. PubMed ID: 17393392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
